News | May 29, 2026
AbbVie wins FDA nod for DECNUPAZ in rare blood cancer
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
For the full year, standalone gross revenue crossed Rs. 1,700 crore
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
The new facility marks Align’s first manufacturing presence in India and its fourth globally
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment
A one-shot gene-editing cholesterol therapy could soon be a reality
Subscribe To Our Newsletter & Stay Updated
